Logo image of CBAT

CBAK ENERGY TECHNOLOGY INC (CBAT) Stock Fundamental Analysis

NASDAQ:CBAT - Nasdaq - US14986C1027 - Common Stock - Currency: USD

0.7043  +0.03 (+5.12%)

After market: 0.7395 +0.04 (+5%)

Fundamental Rating

6

Taking everything into account, CBAT scores 6 out of 10 in our fundamental rating. CBAT was compared to 97 industry peers in the Electrical Equipment industry. Both the profitability and the financial health of CBAT get a neutral evaluation. Nothing too spectacular is happening here. An interesting combination arises when we look at growth and value: CBAT is growing strongly while it also seems undervalued.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year CBAT was profitable.
CBAT had a positive operating cash flow in the past year.
In multiple years CBAT reported negative net income over the last 5 years.
In multiple years CBAT reported negative operating cash flow during the last 5 years.
CBAT Yearly Net Income VS EBIT VS OCF VS FCFCBAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

CBAT's Return On Assets of 3.90% is amongst the best of the industry. CBAT outperforms 81.44% of its industry peers.
CBAT's Return On Equity of 9.69% is amongst the best of the industry. CBAT outperforms 82.47% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.68%, CBAT belongs to the top of the industry, outperforming 85.57% of the companies in the same industry.
Industry RankSector Rank
ROA 3.9%
ROE 9.69%
ROIC 8.68%
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
CBAT Yearly ROA, ROE, ROICCBAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

1.3 Margins

CBAT has a better Profit Margin (6.68%) than 84.54% of its industry peers.
CBAT's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 8.96%, CBAT is doing good in the industry, outperforming 79.38% of the companies in the same industry.
CBAT has a Gross Margin of 26.69%. This is in the better half of the industry: CBAT outperforms 60.82% of its industry peers.
CBAT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 8.96%
PM (TTM) 6.68%
GM 26.69%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
CBAT Yearly Profit, Operating, Gross MarginsCBAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CBAT is still creating some value.
CBAT has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, CBAT has more shares outstanding
CBAT has a better debt/assets ratio than last year.
CBAT Yearly Shares OutstandingCBAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CBAT Yearly Total Debt VS Total AssetsCBAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CBAT has an Altman-Z score of 0.29. This is a bad value and indicates that CBAT is not financially healthy and even has some risk of bankruptcy.
CBAT's Altman-Z score of 0.29 is in line compared to the rest of the industry. CBAT outperforms 53.61% of its industry peers.
CBAT has a debt to FCF ratio of 1.17. This is a very positive value and a sign of high solvency as it would only need 1.17 years to pay back of all of its debts.
CBAT's Debt to FCF ratio of 1.17 is amongst the best of the industry. CBAT outperforms 91.75% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that CBAT is not too dependend on debt financing.
CBAT has a Debt to Equity ratio of 0.22. This is comparable to the rest of the industry: CBAT outperforms 59.79% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.17
Altman-Z 0.29
ROIC/WACC1.59
WACC5.46%
CBAT Yearly LT Debt VS Equity VS FCFCBAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

CBAT has a Current Ratio of 0.82. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.82, CBAT is not doing good in the industry: 80.41% of the companies in the same industry are doing better.
CBAT has a Quick Ratio of 0.82. This is a bad value and indicates that CBAT is not financially healthy enough and could expect problems in meeting its short term obligations.
CBAT's Quick ratio of 0.69 is on the low side compared to the rest of the industry. CBAT is outperformed by 75.26% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.69
CBAT Yearly Current Assets VS Current LiabilitesCBAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

8

3. Growth

3.1 Past

CBAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 316.67%, which is quite impressive.
CBAT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -42.83% yearly.
CBAT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.61%.
The Revenue has been growing by 51.40% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)316.67%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%-400%
Revenue 1Y (TTM)-13.61%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%-54.84%

3.2 Future

CBAT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 48.22% yearly.
CBAT is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.08% yearly.
EPS Next Y-13.69%
EPS Next 2Y48.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.75%
Revenue Next 2Y23.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CBAT Yearly Revenue VS EstimatesCBAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
CBAT Yearly EPS VS EstimatesCBAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0.05 0.1 0.15

9

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.42, the valuation of CBAT can be described as very cheap.
Based on the Price/Earnings ratio, CBAT is valued cheaply inside the industry as 98.97% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.29. CBAT is valued rather cheaply when compared to this.
CBAT is valuated cheaply with a Price/Forward Earnings ratio of 6.28.
Based on the Price/Forward Earnings ratio, CBAT is valued cheaply inside the industry as 95.88% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of CBAT to the average of the S&P500 Index (21.08), we can say CBAT is valued rather cheaply.
Industry RankSector Rank
PE 5.42
Fwd PE 6.28
CBAT Price Earnings VS Forward Price EarningsCBAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CBAT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, CBAT is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.81
EV/EBITDA 2.02
CBAT Per share dataCBAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

The decent profitability rating of CBAT may justify a higher PE ratio.
CBAT's earnings are expected to grow with 48.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.22%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CBAT!.
Industry RankSector Rank
Dividend Yield N/A

CBAK ENERGY TECHNOLOGY INC

NASDAQ:CBAT (4/17/2025, 8:05:51 PM)

After market: 0.7395 +0.04 (+5%)

0.7043

+0.03 (+5.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)03-17 2025-03-17/bmo
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners2.07%
Inst Owner Change-0.01%
Ins Owners19.76%
Ins Owner Change0%
Market Cap63.34M
Analysts0
Price Target2.04 (189.65%)
Short Float %1.44%
Short Ratio3.44
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-345.1%
Min EPS beat(2)-590.2%
Max EPS beat(2)-100%
EPS beat(4)1
Avg EPS beat(4)121.57%
Min EPS beat(4)-590.2%
Max EPS beat(4)1178.43%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-37.46%
Min Revenue beat(2)-50.36%
Max Revenue beat(2)-24.56%
Revenue beat(4)0
Avg Revenue beat(4)-27.05%
Min Revenue beat(4)-50.36%
Max Revenue beat(4)-8.15%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-100%
EPS NQ rev (3m)-100%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-19.75%
Revenue NY rev (1m)-2.67%
Revenue NY rev (3m)-2.67%
Valuation
Industry RankSector Rank
PE 5.42
Fwd PE 6.28
P/S 0.36
P/FCF 2.81
P/OCF 1.6
P/B 0.52
P/tB 0.52
EV/EBITDA 2.02
EPS(TTM)0.13
EY18.46%
EPS(NY)0.11
Fwd EY15.93%
FCF(TTM)0.25
FCFY35.55%
OCF(TTM)0.44
OCFY62.68%
SpS1.96
BVpS1.35
TBVpS1.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.9%
ROE 9.69%
ROCE 12.13%
ROIC 8.68%
ROICexc 9.33%
ROICexgc 9.35%
OM 8.96%
PM (TTM) 6.68%
GM 26.69%
FCFM 12.75%
ROA(3y)-0.27%
ROA(5y)3.43%
ROE(3y)-0.16%
ROE(5y)6.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-61.47%
PM growth 5YN/A
GM growth 3Y32.43%
GM growth 5Y33.2%
F-Score7
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF 1.17
Debt/EBITDA 1.11
Cap/Depr 216.06%
Cap/Sales 9.73%
Interest Coverage 38.8
Cash Conversion 166.92%
Profit Quality 190.99%
Current Ratio 0.82
Quick Ratio 0.69
Altman-Z 0.29
F-Score7
WACC5.46%
ROIC/WACC1.59
Cap/Depr(3y)245.38%
Cap/Depr(5y)296.85%
Cap/Sales(3y)10.68%
Cap/Sales(5y)16.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)316.67%
EPS 3Y-42.83%
EPS 5YN/A
EPS Q2Q%-400%
EPS Next Y-13.69%
EPS Next 2Y48.22%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-13.61%
Revenue growth 3Y49.65%
Revenue growth 5Y51.4%
Sales Q2Q%-54.84%
Revenue Next Year10.75%
Revenue Next 2Y23.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y367.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.63%
OCF growth 3YN/A
OCF growth 5YN/A